CD274 and neoplasm: The signaling pathway of programmed cell death ligand 1 (PD-L1, B7-H1, or CD274) and its receptor PD-1 (CD279) is an important mechanism tumors use to escape antitumor immune responses (2, 3) and maintain an immunosuppressive state in the tumor environment (4).